Automotive and Transportation
Source : (remove) : NBC New York
RSS • JSON • XML • CSV
Automotive and Transportation
Source : (remove) : NBC New York
RSS • JSON • XML • CSV

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom


  Copy link into your clipboard //automotive-transportation.news-articles.net/co .. -investments-as-trump-s-pharma-tariffs-loom.html
  Print publication without navigation Published in Automotive and Transportation on by
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source

  Tariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.


The article from NBC New York discusses how several pharmaceutical companies are making new investments in the U.S. amid looming tariffs on Chinese pharmaceuticals proposed by former President Donald Trump. Companies like Eli Lilly, Merck, and Pfizer are expanding their U.S. operations, with Eli Lilly investing $450 million in a new manufacturing facility in North Carolina, Merck planning a $1 billion expansion in Virginia, and Pfizer announcing a $1.5 billion investment in North Carolina. These investments are seen as a strategic move to mitigate the impact of potential tariffs, which could increase costs for drugs imported from China. The article highlights that these expansions not only aim to bolster domestic production but also to create jobs and enhance the companies' capabilities in the U.S. market.

Read the Full NBC New York Article at:
[ https://www.nbcnewyork.com/news/business/money-report/healthy-returns-here-are-the-drugmakers-with-new-u-s-investments-as-trumps-pharma-tariffs-loom/6245295/ ]